Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health (OPCH) furnished an update on its business by announcing it issued a press release with third quarter 2025 financial results. The press release is attached as Exhibit 99.1 to this Form 8-K. The company states the materials are furnished, not filed, which limits Exchange Act liability and incorporation by reference unless specifically noted.
The press release includes non-GAAP financial measures with reconciliations to the most comparable GAAP metrics. OPCH’s common stock trades on the Nasdaq Global Select Market under the symbol OPCH.
Option Care Health reported a Form 4 disclosing that Meenal Sethna, the company’s Chief Financial Officer, received an award of 55,067 restricted stock units in a transaction dated 10/01/2025. The units were issued at a price of $0 and are shown as directly beneficially owned at 55,067 shares following the award. The filing notes the restricted stock units "vest on the third anniversary of the grant date," and the Form 4 was signed on behalf of Ms. Sethna by an attorney-in-fact on 10/03/2025. The disclosure is a standard insider compensation award reported under Section 16 rules and contains no additional financial results, sales, or derivative transactions.
Option Care Health CFO Meenal Sethna filed an initial Form 3 under Section 16 reporting her relationship to the issuer as Chief Financial Officer and a director/officer. The filing states no securities are beneficially owned as of the event date 10/01/2025, and the form was signed on 10/03/2025.
Option Care Health entered into a Fourth Amendment to its First Lien Credit Agreement that refinances its existing term loans into a new seven-year tranche priced at Term SOFR plus 1.75%. The amendment also provides for incremental term loans totaling $49,639,386.20 at the same rate and maturity, and extends the maturity of the revolving credit commitments to the fifth anniversary of the amendment, subject to a springing maturity 91 days prior to the Unsecured Notes maturity if any Unsecured Notes remain outstanding. After the amendment, the principal amount of First Lien Term Loan indebtedness is approximately $678,000,000. The amendment was executed by the company and Bank of America, N.A., as administrative agent.
Option Care Health director Norman L. Wright purchased 3,411 shares of OPCH common stock on 09/09/2025 at a weighted average price of $29.3099 per share, with individual purchase prices ranging from $29.28 to $29.31. After the transactions, the reporting person beneficially owned 15,501 shares. The Form 4 was signed by Michael Shapiro as attorney-in-fact on 09/10/2025. No derivative securities were reported in this filing.
Pate R. Carter, a director of Option Care Health, Inc. (OPCH), reported purchasing 750 shares of the company's common stock on 08/20/2025 at a weighted average price of $27.1886 per share. After the reported purchase the filing shows the reporting person beneficially owns 41,910 shares. The transaction is coded "P" (purchase). The explanatory note states the 750 shares were bought in multiple transactions with prices ranging from $27.18 to $27.1899, and the reporter will provide detailed per-trade quantities and prices upon request. The Form 4 was signed on behalf of Mr. Carter by an attorney-in-fact.
Option Care Health director Harry M. Kraemer Jr. purchased 36,000 shares of common stock on 08/20/2025 at a weighted average price of $27.1466 per share, increasing his direct beneficial ownership to 375,390 shares. The Form 4 reports the purchases were executed in multiple transactions with individual prices ranging from $26.92 to $27.20 per share, and notes the reporting person will provide detailed allocation information upon request. The filing identifies Mr. Kraemer as a director and indicates the transaction code as "P" for purchase.
Option Care Health director Timothy P. Sullivan reported an open-market purchase of common stock on 08/21/2025. The Form 4 shows a purchase (transaction code P) of 20,000 shares at $27.51 per share, bringing his beneficial ownership to 49,229 shares, held directly. The filing was signed on behalf of Mr. Sullivan by an attorney-in-fact, Michael Shapiro.
Insider purchase disclosed: Option Care Health director David W. Golding acquired 1,000 shares of the company's common stock on 08/21/2025 at a price of $27.625 per share. After the purchase, Mr. Golding beneficially owned 116,525 shares, held directly. The Form 4 was signed on behalf of Mr. Golding by attorney-in-fact Michael Shapiro.
Option Care Health, Inc. filed a Current Report on Form 8-K that attaches an Employment Offer Letter dated August 19, 2025 between the company and Meenal A. Sethna, and a Transition Agreement and Release dated August 19, 2025 between Option Care Enterprises, Inc. and Michael Shapiro. The filing also includes a Press Release dated August 20, 2025 as an exhibit and the cover page formatted in Inline XBRL. The report is signed on behalf of the company by Michael Shapiro, Chief Financial Officer on August 20, 2025.